IRONMAN: Which marker of iron deficiency best predicts response to intravenous iron in patients with heart failure?

Back

HFA Premium Access

IRONMAN: Which marker of iron deficiency best predicts response to intravenous iron in patients with heart failure?

Session: Late breaking clinical trials

Topic: Pharmacotherapy

Speaker: Professor J. Cleland (Glasgow, GB)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

82 presentations

13 followers

5 more presentations in this session

IRONMAN: Effect of intravenous iron according to age

Speaker: Professor I. Squire (Leicester, GB)

Access

Slides

Video

Dapagliflozin and PAD in HF

Speaker: Doctor J. Butt (Copenhagen, DK)

Access

Slides

Video

FINEARTS-HF: Design and Baseline Characteristics

Speaker: Professor S. Solomon (Boston, US)

Access

Slides

Video

Reasons for hospitalisation and mode of death for patients with heart failure and iron deficiency in the IRONMAN randomized trial.

Speaker: Professor J. Cleland (Glasgow, GB)

Access

Slides

Video

IRONMAN: anaemia, iron deficiency and quality of life in heart failure and its response to IV iron

Speaker: Professor P. Kalra (Portsmouth, GB)

Access

Slides

Video

Access the full session

Late breaking clinical trials

Speakers: Professor J. Cleland, Professor I. Squire, Doctor J. Butt, Professor S. Solomon, Professor J. Cleland...

Access

Video

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources